Abstract
The route of administration for a drug should be selected to achieve an effective concentration at the site of action as conveniently as possible. Important subsidiary objectives may be rapidity of onset and duration of drug effect and, in some instances, selectivity of action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bass, M.: Sudden sniffing death. J. Amer. med. Ass. 212, 2075–2079 (1970).
Beckett, A.H., Hossie, R.D.: Buccal absorption of drugs, pp. 25–45. In: Brodie, B.B., Gillette, J.R. (Eds.): Concepts in biochemical pharmacology, Part I. Berlin-Heidelberg-New York: Springer 1971.
Bianchine, J.R., Calimlim, L.R., Morgan, J.P., Dujuvne, C.A., Lasagna, L.: Metabolism and absorption of L-3, 4 dihydroxyphenylalanine in patients with Parkinson’s disease. Ann. N. Y. Acad. Sci. 179, 126–140 (1971).
Boyes, R.N., Adams, H. J., Duce, B.P.: Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs. J. Pharmacol, exp. Ther. 174, 1–8 (1970).
Boyes, R.N., Keenaghan, J.B.: Some aspects of the metabolism and distribution of lidocaine in rats, dogs and man. In: Scott, D.B., Julian, D.G. (Eds.): Lidocaine in the treatment of ventricular arrhythmias, pp. 140–151. Edinburgh: Livingston 1971.
Boyes, R.N., Scott, D.B., Jebson, P.J., Goodman, M. J., Julian, D.G.: Pharmacokinetics of lidocaine in man. Clin. Pharm. Therap. 12, 105–116 (1971).
Brazeau, P.: Inhibitors of tubular transport of organic compounds. In: Goodman, L.S., Gilman, A. (Eds.): The pharmacological basis of therapeutics, p. 897. New York: MacMillan 1970a.
Brazeau, P.: Agents affecting the renal conservation of water. In: Goodman, S., Gilman, A. (Eds.): The pharmacological basis of therapeutics, p. 881. New York: MacMillan 1970b.
Brodie, B.B., Lowman, E.W., Burns, J.J., Lee, P.R., Cherkin, T., Goldman, A., Weiner, M., Steele, J.M.: Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone. Amer. J. Med. 16, 181–190 (1954).
Burchell, H.B.: Clinical problems related to surgical repair of intracardiac defects with the aid of an extracorporeal pump-oxygenator. Circulation 16, 976–987 (1957).
Butler, J.: Percutaneous absorption of tritium-labelled Betamethazone-17-valerate. Brit. J. Derm. 78, 665–668 (1966).
Coltart, D. J., Shand, D.G.: Plasma propranolol levels in the quantitative assessment of B-adrenergic blockade in man. Brit. med. J. 1970 III, 731–734.
Conolly, M.E., Davies, D.S., Dollery, C.T., Morgan, C.D., Paterson, J.W., Sandler, M.: Metabolism of isoprenaline in dog and man. Brit. J. Pharmacol. In press (1972).
Curry, S.H.: Chlorpromazine: Concentrations in plasma, excretion in urine and duration of effect. Proc. roy. Soc. Med. 64, 285–289 (1971).
Curry, S.H., D’Mello, A., Mould, G.P.: Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Brit. J. Pharmacol. 42, 403–411 (1971).
Curry, S.H.: Action and metabolism of chlorpromazine. In: Davies, D.S., Prichard, B.N.C. (Eds.): Biological effects of drugs in relation to their plasma concentrations. London: MacMillan in press (1972).
Davidson, I. W. F., Rollins, F. O., Di Carlo, F. J., Miller, H. S., Jr.: The pharmacodynamics and biotransformation of penta-erythritol trinitrate in man. Clin. Pharmacol. 12, 972–981 (1971).
Dollery, C.T.: Absorption, distribution and excretion of drugs used to treat hypertension. In: Binns, T. B. (Ed.): Absorption and distribution of drugs, p. 157. Edinburgh: Livingston 1964.
Dollery, C.T., Davies, D.S., Conolly, M.E.: Differences in the metabolism of drugs depending on their routes of administration. Ann. N. Y. Acad. Sci. 179, 108–114 (1971).
Eger, E.I.II., Larson, O.P., Jr.: Anaesthetic solubility in blood and tissues: values and significance. Brit. J. Anaesth. 36, 140–149 (1964).
Ellard, G. A., Garrod, J.M.B., Scales, B., Snow, G.A.: Percutaneous absorption and routes of excretion of ditophal (Etisul). Biochem. Pharmacol. 12, 271–281 (1963).
Enna, S.J., Shanker, L.S.: Drug absorption from the lung. Fed. Proc. Fed. Amer. Soc. exp. Biol. 28, 359 (1969).
Franch, R.H.: Cardiac catheterization. In: Hurst, J.W., Logue, R.B. (Eds.): The heart, pp. 164–192. New York: McGraw-Hill 1966.
Harrison, D.C.: In: Scott, D.B., Julian, D.G. (Eds.): Lidocaine in the treatment of ventricular arrhythmias, p. 166. Edinburgh: Livingston 1971.
Hayes, A., Cooper, R.G.: Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey. J. Pharmacol, exp. Ther. 176, 302–311 (1971).
Herbert, V.: Drugs effective in megaloblastic anaemias. In: Goodman, L. S., Gdlman, A. (Eds.): The pharmacological basis of therapeutics, p. 1429, 4th ed. New York: MacMillan 1970.
Hollister, L.E., Curry, S.H., Derr, J.E., Kanter, S.L.: Studies of delayed-action medication: V. plasma levels and urinary excretion of four different dosage forms of chlor-promazine. Clin. Pharmacol. Ther. 11, 49–59 (1970).
James, V.H.T., Munro, D.D., Feiwel, M.: Pituitary-adrenal function after occlusive topical therapy with Betamethasone-11-valerate. Lancet 1967 II, 1059–1061.
Jewitt, D.E., Kishon, Y., Thomas, M.: Lignocaine in the management of arrhythmias after acute myocardial infarction. Lancet 1968 I, 266–270.
Jones, R. J.: Medical control of Adams-Stokes syndrome. J. Amer. med. Ass. 167, 1840–1842 (1958).
Katz, M., Poulsen, B. J.: Absorption of drugs through the skin. In: Brodle, B.B., Gillette, J.R. (Eds.): Concepts in biochemical pharmacology, Part I, pp. 103–162. Berlin-Heidelberg-New York: Springer 1971.
Levy, G.: Kinetics and implications of dissolution-rate-limited gastrointestinal absorption of drugs. In: Arins, E. J. (Ed.): Physicochemical aspects of drug actions. Proceedings of the third International Pharmacological Meeting, Vol. 7, pp. 33–62. Oxford: Pergamon 1968.
McCarthy, C.G., Finland, M.: Absorption and excretion of four penicillins. New Engl. J. Med. 263, 315–326 (1960).
McDermott, W., Bunn, P.A., Benoit, M., Dubois, R., Reynolds, M.E.: The absorption, excretion and destruction of orally administered penicillin. J. clin. Invest. 25, 190–210 (1946).
Minatoya, H., Lands, A.M., Portmann, G.A.: Absorption and elimination profile of isoproterenol. I. J. Pharm. Sci. 54, 968–972 (1965).
Mroczek, W.J., Leibel, B.A., Davidov, M., Finnerty, F.A.: The importance of the rapid administration of diazoxide in accelerated hypertension. New Engl. J. Med. 285, 603–606 (1971).
Papper, E.M.: The pharmacokinetics of inhalation anaesthetics: clinical application. Brit. J. Anaesth. 36, 124–128 (1964).
Paterson, J.W., Conolly, M.E., Davies, D.S., Dollery, C.T.: Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet 1968 II, 426–429.
Paterson, J.W., Conolly, M.E., Dollery, C.T., Hayes, A., Cooper, R.G.: The pharmacodynamics and metabolism of propranolol in man. Pharmacologia Clinica 2, 127–133 (1970).
Portmann, G.A., Minatoya, H., Lands, A.M.: Absorption and elimination profile of isoproterenol. II. J. Pharm. Sci. 54, 973–978 (1965).
Price, H. L.: A dynamic concept of the distribution of thiopental in the human body. Anesthesiology 21, 40–45 (1960).
Rowland, M., Thomson, P.D., Guichard, A., Melmon, K.L.: Disposition kinetics of lidocaine in normal subjects. Ann. N. Y. Acad. Sci. 179, 383–399 (1971).
Schou, J.: Subcutaneous and intramuscular injection of drugs. In: Brodle, B.B., Gillette, J.R. (Eds.): Concepts in biochemical pharmacology, Part I, pp. 47–63. Berlin-Heidelberg-New York: Springer 1971.
Schumacher, E.E. Jr., Schmock, C.L.: The control of certain cardiac arrhythmias with iso-propylnorepinephrine. Amer. Heart J. 48, 933–940 (1954).
Sellers, E. M., Koch-Weser, J.: Protein binding and vascular activity of diazoxide. New Engl. J. Med. 281, 1141–1145 (1969).
Shand, D.G., Evans, G.H., Nies, A. S.: The almost complete hepatic extraction of propranolol during intravenous administration in the dog. Life Sci. Part I 10, 1417–1421 (1971).
Shanker, L.S.: Absorption of drugs from the gastro-intestinal tract. In: Brodie, B.B., Gillette, J.R. (Eds.): Concepts in biochemical pharmacology Part I, pp. 9–23. Berlin-Heidelberg-New York: Springer 1971.
Speizer, P.E., Doll, R., Heaf, P.: Investigation into use of drugs preceding death from asthma. Brit. med. J. 1, 339–343 (1968).
Stenson, R.E., Constantino, R. T., Harrison, D.C.: Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation 43, 205–211 (1971).
Thomson, P.D., Rowland, M., Melmon, K.L.: The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. Amer. Heart J. 82, 417–421 (1971).
Walker, S.R., Evans, M.E., Richards, A.J., Paterson, J.W.: The fate of 14C disodium cromoglycate in man. J. Pharm. Pharmacol. In press (1972).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Dollery, C.T., Davies, D.S. (1975). Routes of Administration and Drug Response. In: Gillette, J.R., Mitchell, J.R. (eds) Concepts in Biochemical Pharmacology. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 28 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46314-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-46314-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46316-7
Online ISBN: 978-3-642-46314-3
eBook Packages: Springer Book Archive